ERCC5 and cancer: By comparing the differences in mutation genes between the two groups (Figure 4A), it was observed that the XPA and NF2 genes were significantly more frequently mutated in the group with a family history of cancer (P <0.05), while the ERCC5 and TSC1 genes were more common in the group without a family history of cancer (P <0.05).